Effect of Probiotics on Patients With Congenital Heart Disease Following Cardiopulmonary Bypass

NACompletedINTERVENTIONAL
Enrollment

80

Participants

Timeline

Start Date

June 1, 2021

Primary Completion Date

July 1, 2022

Study Completion Date

July 1, 2022

Conditions
Congenital Heart DiseaseIntestinal DiseaseDysbiosis
Interventions
DIETARY_SUPPLEMENT

probiotics containing Bifidobacterium infantis and Lactobacillus

Patients were provided with probiotics containing Bifidobacterium infantis and Lactobacillus. This intervention was started the day after patients' administration and lasted until the day before discharge.

DIETARY_SUPPLEMENT

placebos containing lactose

Patients received lactose as placebo.This intervention was started the day after patients' administration and lasted until the day before discharge.

Trial Locations (1)

210093

Children's Hospital of Nanjing Medical University, Nanjing

All Listed Sponsors
lead

Nanjing Children's Hospital

OTHER